Inventor
PANDA MANORANJAN
IN16 patents
⚠️ This page may combine multiple inventors who share the name “PANDA MANORANJAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS11267811B2Mar 8, 2022
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO4 citations72
US11072626B2Jul 27, 2021
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO3 citations71
US10611776B2Apr 7, 2020
Spiroheptane salicylamides and related compounds as inhibitors of rock
BRISTOL MYERS SQUIBB CO1 citations61
USRE49700EOct 17, 2023
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO0 citations60
US10501449B2Dec 10, 2019
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO1 citations60
US11639353B2May 2, 2023
Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11014922B2May 25, 2021
Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US12269819B2Apr 8, 2025
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US11970511B2Apr 30, 2024
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US10829501B2Nov 10, 2020
Spiroheptane salicylamides and related compounds as inhibitors of ROCK
BRISTOL MYERS SQUIBB CO0 citations50
US12286424B2Apr 29, 2025
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO0 citations47
US12473304B2Nov 18, 2025
Heterocyclic PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations43
US10723723B2Jul 28, 2020
Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
US10851108B2Dec 1, 2020
Substituted bicyclic heterocyclic compounds
BRISTOL MYERS SQUIBB CO0 citations34